Close Menu

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    International Ombudsman Forum Establishes Worldwide Independent Defender Union (WIDU)

    November 19, 2026

    Botswana opens consultations on proposed 33 percent hike now

    November 19, 2026

    PM Modi meets Prince and Princess of Wales in New Delhi

    November 19, 2026
    Oran Star: Algeria’s news. Maghreb perspective.Oran Star: Algeria’s news. Maghreb perspective.
    • Automotive
    • Business
    • Entertainment
    • Health
    • Lifestyle
    • Luxury
    • News
    • Sports
    • Technology
    • Travel
    Oran Star: Algeria’s news. Maghreb perspective.Oran Star: Algeria’s news. Maghreb perspective.
    Home » Dana-Farber and 23andMe Research Identify Gene That May Increase Lung Cancer Risk in Non-Smokers by 60-Fold
    Health

    Dana-Farber and 23andMe Research Identify Gene That May Increase Lung Cancer Risk in Non-Smokers by 60-Fold

    September 19, 2026
    Facebook WhatsApp Twitter Pinterest LinkedIn Telegram Tumblr Email Reddit VKontakte

    WASHINGTON / RankWire.AI / – A groundbreaking study published in the journal Science reveals that scientists have pinpointed a rare inherited genetic mutation that can elevate an individual’s risk of developing lung cancer by approximately 25 times overall, and by about 60 times among those who have never smoked, according to findings from researchers at the Dana-Farber Cancer Institute and the 23andMe Research Institute. The investigation analyzed anonymized genetic information from over 3.3 million individuals, with the germline variant, known as EGFR T790M, emerging as one of the most potent inherited risk factors for lung cancer identified to date.

    Gene could raise lung cancer risk 60 times in study
    Medical laboratory researchers conduct DNA sequencing tests inside clinical oncology centers. (AI-generated image)

    This mutation is situated in the epidermal growth factor receptor gene, which plays a key role in controlling cell growth and division within lung tissue. While somatic mutations in EGFR, acquired during a person’s lifetime, are well-established drivers of non-small cell lung cancer, the T790M germline variant is inherited from birth and found in every cell. Data from the National Cancer Institute indicates that roughly 1 in every 15,850 individuals in the United States carries this mutation. Lead author Dr. Jaclyn LoPiccolo pointed out that carriers of the variant face about a 62-fold increased risk of lung cancer among non-smokers, compared to an approximate 11-fold increase among those with a history of smoking.

    Gene genealogy analysis uncovered that the EGFR T790M mutation is disproportionately prevalent in populations across Southern Appalachia, specifically in Tennessee and Alabama. Evolutionary geneticists traced the origin of this mutation to British and Irish settlers who migrated to North America during colonial times, with its frequency increasing following a genetic bottleneck around 200 years ago. Senior study author Dr. Pasi A. Jänne highlighted that, although lung cancer screening is predominantly based on tobacco exposure, recognizing significant genetic risk factors opens avenues for targeted low-dose computed tomography screening in non-smoking carriers.

    Genetic Mutation May Amplify Lung Cancer Risk Up to 60 Times in Non-Smokers

    Supported by the National Institutes of Health, preclinical and clinical trials confirmed that the mutation has a strong specific association with lung cancer, with no significant links to 17 other common cancers examined in the dataset. Oncologists emphasized that while tobacco use remains the primary cause of lung cancer, the growing incidence of non-smoking-related cases has made it a rising global health concern. Several pharmaceutical companies, such as AstraZeneca, are actively developing targeted tyrosine kinase inhibitors, including Tagrisso, to treat lung cancers with EGFR mutations when tumors progress.

    Co-senior author Dr. Alexander Gusev pointed out that the research demonstrates how a single inherited point mutation can exert an exceptionally strong influence on disease susceptibility. Medical professionals advise that individuals with multiple relatives affected by lung cancer, unexplained multifocal lung nodules, or ancestral ties to Southern Appalachia seek guidance from genetic counselors. The researchers stress that possessing the mutation does not ensure a lung cancer diagnosis, as environmental factors and secondary genetic changes also play a role in whether malignant transformation occurs over a lifetime.

    Multicenter Study Analyzes Genetic Data from Over Three Million Participants

    The research alliance aims to broaden observational efforts through the ongoing INHERIT Study, focusing on additional inherited EGFR variants across diverse racial populations. Longitudinal studies will seek to identify specific environmental triggers and secondary genetic alterations that determine why some carriers develop tumors while others remain unaffected.

    Comprehensive data on population genetics, risk assessments, and screening guidelines are available via peer-reviewed medical repositories and institutional release portals. Presentations of updated biomarker findings are scheduled at upcoming international oncology conferences to shape future screening strategies.

    }**q986g4cdxhf**

    Related Posts

    Congo Ebola death toll reaches 5,568 as cases pass 11,000

    November 18, 2026

    Africa CDC says Congo Ebola outbreak still not under control

    November 16, 2026

    WHO reports 67 yellow fever cases in nine African countries

    November 7, 2026

    Bangladesh dengue deaths reach 418 after deadliest month of 2026

    November 2, 2026

    DR Congo Ebola death toll climbs to 5,340 as cases reach 10,351

    November 2, 2026

    DR Congo Ebola cases top 10,000 in fastest-growing outbreak

    October 28, 2026
    Current News

    Botswana opens consultations on proposed 33 percent hike now

    November 19, 2026

    PM Modi meets Prince and Princess of Wales in New Delhi

    November 19, 2026

    Rand slips toward R17 as inflation and weak growth cloud outlook

    November 18, 2026

    Congo Ebola death toll reaches 5,568 as cases pass 11,000

    November 18, 2026

    Prabowo says DEFA can unlock $2 trillion ASEAN digital economy

    November 18, 2026

    DXB handles 50.4 million passengers in first nine months

    November 18, 2026

    Tunisia tourism revenues top $2.38 billion by end-October

    November 17, 2026

    Air Arabia Dammam launches four weekly flights to Damascus

    November 17, 2026
    © 2026 Oran Star | All Rights Reserved
    • Home
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.